Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.

Emer Shannon; Maria Hayes

doi:10.3390/foods14020284

Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.

Emer Shannon
, Maria Hayes

APC Microbiome Ireland

Food Biosciences Department

Research output: Contribution to journal › Article › peer-review

Abstract

Hypertension, type 2 diabetes (T2D), and obesity raise an individual’s risk of suffering from diseases associated with metabolic syndrome (MS). In humans, enzymes that play a role in the prevention and development of MS include angiotensin converting enzyme (ACE-1) associated with hypertension, α-amylase associated with T2D, and lipase linked to the development of obesity. Seaweeds are a rich source of bioactives consisting of proteins/peptides, polysaccharides, and lipids. This study examined the potential of seaweed-derived bioactives from Alaria esculenta, Ulva lactuca, and Palmaria palmata as inhibitors of ACE-1, α-amylase, and lipase.

Original language	English
Article number	284
Number of pages	26
Journal	Foods
Volume	14
Issue number	2
DOIs	https://doi.org/10.3390/foods14020284
Publication status	Published - 16 Jan 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

angiotensin converting enzyme (ACE-1)
functional foods
hypertension
lipase
metabolic syndrome
nutraceuticals
peptides
polyphenols
polysaccharides
seaweed
type 2 diabetes
α-amylase

Access to Document

10.3390/foods14020284

Cite this

@article{08f627d4989f4b68baf6f5c70c1b984c,

title = "Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.",

abstract = "Hypertension, type 2 diabetes (T2D), and obesity raise an individual{\textquoteright}s risk of suffering from diseases associated with metabolic syndrome (MS). In humans, enzymes that play a role in the prevention and development of MS include angiotensin converting enzyme (ACE-1) associated with hypertension, α-amylase associated with T2D, and lipase linked to the development of obesity. Seaweeds are a rich source of bioactives consisting of proteins/peptides, polysaccharides, and lipids. This study examined the potential of seaweed-derived bioactives from Alaria esculenta, Ulva lactuca, and Palmaria palmata as inhibitors of ACE-1, α-amylase, and lipase.",

keywords = "angiotensin converting enzyme (ACE-1), functional foods, hypertension, lipase, metabolic syndrome, nutraceuticals, peptides, polyphenols, polysaccharides, seaweed, type 2 diabetes, α-amylase",

author = "Emer Shannon and Maria Hayes",

note = "Publisher Copyright: {\textcopyright} 2025 by the authors.",

year = "2025",

month = jan,

day = "16",

doi = "10.3390/foods14020284",

language = "English",

volume = "14",

journal = "Foods",

issn = "2304-8158",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "2",

}

TY - JOUR

T1 - Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.

AU - Shannon, Emer

AU - Hayes, Maria

PY - 2025/1/16

Y1 - 2025/1/16

N2 - Hypertension, type 2 diabetes (T2D), and obesity raise an individual’s risk of suffering from diseases associated with metabolic syndrome (MS). In humans, enzymes that play a role in the prevention and development of MS include angiotensin converting enzyme (ACE-1) associated with hypertension, α-amylase associated with T2D, and lipase linked to the development of obesity. Seaweeds are a rich source of bioactives consisting of proteins/peptides, polysaccharides, and lipids. This study examined the potential of seaweed-derived bioactives from Alaria esculenta, Ulva lactuca, and Palmaria palmata as inhibitors of ACE-1, α-amylase, and lipase.

AB - Hypertension, type 2 diabetes (T2D), and obesity raise an individual’s risk of suffering from diseases associated with metabolic syndrome (MS). In humans, enzymes that play a role in the prevention and development of MS include angiotensin converting enzyme (ACE-1) associated with hypertension, α-amylase associated with T2D, and lipase linked to the development of obesity. Seaweeds are a rich source of bioactives consisting of proteins/peptides, polysaccharides, and lipids. This study examined the potential of seaweed-derived bioactives from Alaria esculenta, Ulva lactuca, and Palmaria palmata as inhibitors of ACE-1, α-amylase, and lipase.

KW - angiotensin converting enzyme (ACE-1)

KW - functional foods

KW - hypertension

KW - lipase

KW - metabolic syndrome

KW - nutraceuticals

KW - peptides

KW - polyphenols

KW - polysaccharides

KW - seaweed

KW - type 2 diabetes

KW - α-amylase

UR - https://www.scopus.com/pages/publications/85215988456

U2 - 10.3390/foods14020284

DO - 10.3390/foods14020284

M3 - Article

C2 - 39856950

SN - 2304-8158

VL - 14

JO - Foods

JF - Foods

IS - 2

M1 - 284

ER -

Alaria esculenta, Ulva lactuca, and Palmaria palmata as Potential Functional Food Ingredients for the Management of Metabolic Syndrome.

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this